Verona Pharma plc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.06 | -$0.00 | -$0.02 |
| Q2 2024 | 1 | -$0.07 | -$0.00 | -$0.04 |
| Q3 2024 | 4 | -$0.05 | -$0.04 | -$0.04 |
| Q4 2024 | 1 | -$0.09 | -$0.00 | -$0.04 |
| Q1 2025 | 2 | -$0.08 | -$0.00 | -$0.04 |
| Q2 2025 | 2 | -$0.08 | -$0.00 | -$0.04 |
| Q3 2025 | 2 | -$0.08 | -$0.00 | -$0.04 |
| Q4 2025 | 2 | -$0.07 | -$0.00 | -$0.03 |
Verona Pharma plc Earnings Date And Information
Verona Pharma plc last posted its earnings results on Thursday, August 8th, 2024. The company reported $-0.88 earnings per share for the quarter, missing analysts' consensus estimates of $-0.35 by $0.53. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Verona Pharma plc has generated $-1 earnings per share over the last year ($-0.69 diluted earnings per share) and currently has a price-to-earnings ratio of -18.55. Verona Pharma plc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 5th, 2024 based on prior year's report dates.
Verona Pharma plc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/08/2024 | Q2 2024 | -$0.35 | -$0.88 | -0.53 | $263,336 | $0 |
| 05/10/2024 | Q1 2024 | -$0.32 | $0 | $0 | ||
| 02/29/2024 | Q4 2023 | -$0.23 | -$0.18 | 0.05 | $0 | $940,056 |
| 11/02/2023 | Q3 2023 | -$0.27 | -$0.18 | 0.09 | $0 | |
| 08/03/2023 | Q2 2023 | -$0.27 | -$0.11 | 0.16 | $0 | |
| 05/09/2023 | Q1 2023 | -$0.22 | -$0.22 | 0 | $0 | |
| 03/07/2023 | Q4 2022 | -$0.22 | -$0.14 | 0.08 | $458,000 | |
| 11/09/2022 | Q3 2022 | -$0.30 | -$0.02 | 0.28 | $4.52 M | $0 |
| 08/09/2022 | Q2 2022 | -$0.35 | -$0.03 | 0.32 | $0 | |
| 05/03/2022 | Q1 2022 | -$0.47 | -$0.04 | 0.43 | $0 | |
| 03/03/2022 | Q4 2021 | -$0.50 | -$0.04 | 0.46 | $0 | |
| 11/09/2021 | Q3 2021 | -$0.36 | $0.16 | 0.52 | $4.63 M | $40.00 M |
| 08/05/2021 | Q2 2021 | -$0.39 | -$0.04 | 0.35 | $0 | |
| 04/29/2021 | Q1 2021 | -$0.45 | -$0.04 | 0.41 | $0 | |
| 02/25/2021 | Q4 2020 | -$0.34 | -$0.04 | 0.3 | $0 | |
| 10/29/2020 | Q3 2020 | -$0.21 | -$0.05 | 0.16 | $0 | |
| 08/14/2020 | Q2 2020 | -$0.40 | -$0.07 | 0.33 | $0 | |
| 08/14/2020 | Q1 2020 | -$0.40 | -$0.09 | 0.31 | $0 | |
| 02/27/2020 | Q4 2019 | -$1.12 | -$0.06 | 1.06 | $2,351 | |
| 11/05/2019 | Q3 2019 | -$0.89 | -$0.09 | 0.8 | $0 |
Verona Pharma plc Earnings: Frequently Asked Questions
-
When is Verona Pharma plc's earnings date?
Verona Pharma plc has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 5th, 2024 based off last year's report dates.
-
How can I listen to Verona Pharma plc's earnings conference call?
The conference call for Verona Pharma plc's latest earnings report can be listened to online.
-
How can I read Verona Pharma plc's conference call transcript?
The conference call transcript for Verona Pharma plc's latest earnings report can be read online.
-
How much profit does Verona Pharma plc generate each year?
Verona Pharma plc (:VRNA) has a recorded net income of $0. Verona Pharma plc has generated $-0.69 earnings per share over the last four quarters.
-
What is Verona Pharma plc's price-to-earnings ratio?
Verona Pharma plc (:VRNA) has a price-to-earnings ratio of -18.55 and price/earnings-to-growth ratio is -0.55.
